Bone drug may cut breast cancer risk in women with dense breasts
NCT ID NCT04067726
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study tests whether denosumab, a drug used for bone health, can reduce breast density in premenopausal women with dense breasts. High breast density is a known risk factor for breast cancer. The trial involves 210 women and aims to see if lowering density could open new ways to prevent breast cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENSE BREASTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.